Observational studyEuropean geriatric medicine2026
Hospital at home for older patients with heart failure: an observational study of the GIROT experience.
Observational study in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHeart failure (HF) is a leading cause of hospitalization in older adults and is associated with frequent readmissions within 30 days after discharge. GIROT (Gruppo Intervento Rapido Ospedale-Territorio) model, an example of Hospital at Home (HaH) model, provides home-based care for older patients with acute conditions. This study aimed to compare hospital admissions in the 30-day and 6-month periods before and after GIROT referral.
methodsThis retrospective observational study included patients ≥ 65 years with HF, referred to GIROT between March 2022 and April 2024. Given the lack of a control group, an intra-patient comparison of the number of hospital admissions in the 30-day and 6-month periods before and after GIROT referral was performed using the Wilcoxon signed-rank test. Predictors of all-cause 6-month mortality were investigated using multivariate logistic regression.
resultsAmong 157 included participants (mean age 89; female 63.1%, 75% with moderate-to-severe disability), the number of hospital admissions decreased from a median of 1.0 to 0.0 at 1 month and from 1.0 to 0.0 at 6 months (both p < 0.001, Wilcoxon signed-rank test). Six-month mortality rate was 47%, with severe disability at the end of GIROT service period emerging as the independent predictor (OR 1.42, 95% CI 1.17-1.69). Patient and caregiver satisfaction was high (84%).
conclusionThe GIROT HaH model was associated with a reduction in hospital admissions in the 1 and 6 months following the intervention in old patients with HF. Functional status, rather than comorbidities, independently predicted 6-month mortality. Further prospective studies including control groups are needed to better assess the effectiveness of this model.
Indexed as
Identifiers
42084710What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.